BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29747062)

  • 1. Biochemical characterization of a recombinant Lactobacillus acidophilus strain expressing exogenous FomA protein.
    Ma L; Li F; Zhang X; Feng X
    Arch Oral Biol; 2018 Aug; 92():25-31. PubMed ID: 29747062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of recombinant FomA-expressing Lactobacillus acidophilus against periodontal infection.
    Ma L; Ding Q; Feng X; Li F
    Inflammation; 2013 Oct; 36(5):1160-70. PubMed ID: 23644821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat-killed Lactobacillus acidophilus mediates Fusobacterium nucleatum induced pro-inflammatory responses in epithelial cells.
    Ding Q; Sun X; Cao S; Zhao C; Wang Y; Wang X
    FEMS Microbiol Lett; 2021 Apr; 368(5):. PubMed ID: 33693760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis.
    Liu PF; Shi W; Zhu W; Smith JW; Hsieh SL; Gallo RL; Huang CM
    Vaccine; 2010 Apr; 28(19):3496-505. PubMed ID: 20189489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective potential of non-dialyzable material fraction of cranberry juice on the virulence of P. gingivalis and F. nucleatum mixed infection.
    Polak D; Naddaf R; Shapira L; Weiss EI; Houri-Haddad Y
    J Periodontol; 2013 Jul; 84(7):1019-25. PubMed ID: 23030239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquisition and the immunogenicity of the outer membrane FomA protein of
    Ma L; Feng XP; Wu QL; Zhang XY; Zhang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Oct; 53(10):674-680. PubMed ID: 30392224
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis.
    Polak D; Wilensky A; Shapira L; Weiss EI; Houri-Haddad Y
    J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological Pathways Triggered by
    de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
    Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
    [No Abstract]   [Full Text] [Related]  

  • 9. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum.
    Liu PF; Huang IF; Shu CW; Huang CM
    Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of coaggregation between Porphyromonas gingivalis and Fusobacterium nucleatum on the host response to mixed infection.
    Polak D; Shapira L; Weiss EI; Houri-Haddad Y
    J Clin Periodontol; 2012 Jul; 39(7):617-25. PubMed ID: 22607053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.
    Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ
    Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
    Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
    J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum.
    Onoue S; Imai T; Kumada H; Umemoto T; Kaca W; Isshiki Y; Kaneko A; Kawahara K
    Microbiol Immunol; 2003; 47(1):51-5. PubMed ID: 12636253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA.
    Zhang Z; Liu S; Zhang S; Li Y; Shi X; Liu D; Pan Y
    J Periodontol; 2022 Apr; 93(4):515-525. PubMed ID: 34458990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic pathogenicity of Porphyromonas gingivalis and Fusobacterium nucleatum in the mouse subcutaneous chamber model.
    Metzger Z; Lin YY; Dimeo F; Ambrose WW; Trope M; Arnold RR
    J Endod; 2009 Jan; 35(1):86-94. PubMed ID: 19084132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A preliminary study on the effect of histatin 5 inhibiting
    Wang HY; Liu JW; Li Q; Tan LS; Lin L; Pan YP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Mar; 53(3):150-156. PubMed ID: 29972970
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum.
    Metzger Z; Blasbalg J; Dotan M; Weiss EI
    J Endod; 2009 Jan; 35(1):82-5. PubMed ID: 19084131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of the fomA gene, encoding the major outer membrane porin of Fusobacterium nucleatum ATCC10953.
    Jensen HB; Skeidsvoll J; Fjellbirkeland A; Høgh B; Puntervoll P; Kleivdal H; Tommassen J
    Microb Pathog; 1996 Nov; 21(5):331-42. PubMed ID: 8938641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.
    Nakagaki H; Sekine S; Terao Y; Toe M; Tanaka M; Ito HO; Kawabata S; Shizukuishi S; Fujihashi K; Kataoka K
    Infect Immun; 2010 Mar; 78(3):1185-92. PubMed ID: 20008529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed infection with Porphyromonas gingivalis and Fusobacterium nucleatum in a murine lesion model: potential synergistic effects on virulence.
    Feuille F; Ebersole JL; Kesavalu L; Stepfen MJ; Holt SC
    Infect Immun; 1996 Jun; 64(6):2094-100. PubMed ID: 8675312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.